Impact of Plasma on Dendritic Cell Maturation in Peripartum Cardiomyopathy
Author Information
Author(s): JANE E. ELLIS, AFTAB A. ANSARI, JAMES D. FETT, ROBERT D. CARRAWAY, HUGH W. RANDALL, MARIO I. MOSUNJAC, J. BRUCE SUNDSTROM
Primary Institution: Emory University School of Medicine
Hypothesis
The study investigates whether plasma from patients with peripartum cardiomyopathy (PPCM) inhibits the maturation of dendritic cells compared to plasma from healthy postpartum controls.
Conclusion
Plasma from PPCM patients significantly reduces the maturation of dendritic cells, which may contribute to the pathogenesis of the disease.
Supporting Evidence
- Plasma from PPCM patients showed significantly reduced potential for inducing dendritic cell maturation.
- Elevated levels of biomarkers associated with cardiac tissue remodeling were found in PPCM subjects.
- Significant differences in left ventricular ejection fraction were observed between PPCM and control subjects.
Takeaway
Women with a heart condition called peripartum cardiomyopathy have blood that makes it harder for certain immune cells to grow up and do their job.
Methodology
The study involved testing plasma samples from 12 PPCM patients and 12 control subjects for their ability to induce maturation of cord blood-derived dendritic cells in vitro.
Potential Biases
Potential bias may arise from the selection of control subjects and the specific characteristics of the Haitian population studied.
Limitations
The study is limited by the small sample size and the specific population studied, which may not be generalizable.
Participant Demographics
Participants were Haitian women, age- and parity-matched, with 12 having PPCM and 12 as controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website